These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 21042204)
1. Novel role of puberty onset protein kisspeptin as an anticoagulation peptide. Qureshi IZ; Kanwal S Blood Coagul Fibrinolysis; 2011 Jan; 22(1):40-9. PubMed ID: 21042204 [TBL] [Abstract][Full Text] [Related]
2. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021 [TBL] [Abstract][Full Text] [Related]
3. Preparation and anticoagulation activity of sodium cellulose sulfate. Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735 [TBL] [Abstract][Full Text] [Related]
4. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
5. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample. Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats. Pehrsson S; Johansson K; Kjaer M; Elg M Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126 [TBL] [Abstract][Full Text] [Related]
7. SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity. Berry CN; Lassalle G; Lunven C; Altenburger JM; Guilbert F; Lalé A; Hérault JP; Lecoffre C; Pfersdorff C; Herbert JM; O'Connor SE J Pharmacol Exp Ther; 2002 Dec; 303(3):1189-98. PubMed ID: 12438543 [TBL] [Abstract][Full Text] [Related]
8. [A study of human annexin V derivative: its effects of anticoagulation and antithrombosis]. Ju CW; Wang LS; Yang X; Ma GS; Hua ZC; Gao XY Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):540-3. PubMed ID: 15569533 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of TAK-442, a novel orally active direct factor Xa inhibitor, and ximelagatran, a thrombin inhibitor, on factor V-mediated feedback on coagulation cascade and bleeding. Konishi N; Hiroe K; Kawamura M Thromb Haemost; 2010 Sep; 104(3):504-13. PubMed ID: 20664909 [TBL] [Abstract][Full Text] [Related]
10. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system. Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900 [TBL] [Abstract][Full Text] [Related]
11. [Heparin level and coagulation potential after subcutaneous injection of 7500 international units of heparin calcium]. Briel RC Dtsch Med Wochenschr; 1984 Jun; 109(25):993-6. PubMed ID: 6734457 [TBL] [Abstract][Full Text] [Related]
12. [The anticoagulant action of the nitric acid ester of oxidized starch]. Samal' AB; Koliadko MG; Sogrina EN; Iurkshtovich TL; Sidorenko GI Eksp Klin Farmakol; 1996; 59(2):27-30. PubMed ID: 8974559 [TBL] [Abstract][Full Text] [Related]
13. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H. Bagdy D; Barabás E; Szabó G; Bajusz S; Széll E Thromb Haemost; 1992 Mar; 67(3):357-65. PubMed ID: 1641827 [TBL] [Abstract][Full Text] [Related]
14. Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats. Chan KC; Yin MC; Chao WJ Food Chem Toxicol; 2007 Mar; 45(3):502-7. PubMed ID: 17123684 [TBL] [Abstract][Full Text] [Related]
15. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Fonseca RJ; Mourão PA Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379 [TBL] [Abstract][Full Text] [Related]
16. Effects of 6-(4-chlorophenoxy)-tetrazolo[5,1-a]phthalazine on anticoagulation in mice and the inhibition of experimental thrombosis in rats. Yu HL; Zhang F; Lan T; Quan ZS J Cardiovasc Pharmacol; 2014 Dec; 64(6):560-6. PubMed ID: 25165995 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637. Deinum J; Mattsson C; Inghardt T; Elg M Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation]. Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345 [TBL] [Abstract][Full Text] [Related]